In the latest edition of the British Society for Allergy and Clinical Immunology’s (BSACI) journal, the editor in chief Professor Roberts has included reference to the prescribing of adrenaline auto-injectors in his opening editorial. You can read this here.
Lynne Regent, CEO, the Anaphylaxis Campaign said; “We are encouraged to see that the BSACI have acknowledged our feedback to the guidance, particularly around the prescription of adrenaline auto-injectors (AAIs) and the number allocated. The position of the Anaphylaxis campaign remains that two AAIs are available to patients at all times.”
Professor Roberts states, “The patient groups have pointed out that not all doctors have the necessary skills to make this assessment, emergency medical response times are increasing and the MHRA has advised that two auto-injectors should be prescribed. In these issues of the Journal, the guideline authors respond to correspondence from Allergy UK and the Anaphylaxis Campaign [http://onlinelibrary.wiley.com/doi/10.1111/cea.12855/epdf]. The BSACI have also promised to provide additional guidance for doctors working in primary care.”
You can read our original response here: http://onlinelibrary.wiley.com/doi/10.1111/cea.12852/epdf
We need your support to ensure we can continue to campaign strongly on these issues. To make a donation please click on this link.